Mexico City (June 12, 2012) As the annual G20 Summit convenes in Mexico this week, advocates from AIDS Healthcare Foundation (AHF) and the African Council of AIDS Service Organizations (AFRICASO), will host a press conference Thursday, June 14th at the Presidente InterContinental Hotel in Mexico City to urge all G20 member nations the US, Canada, France, Germany, Italy, Japan, Russia and the United Kingdom (the G8 countries) as well as Mexico, Argentina, Australia, Brazil, China, India, Indonesia, South Africa, South Korea, Saudi Arabia, Spain, Turkey and the European Union to greatly step up funding for the worldwide fight against AIDS, which many AIDS advocates believe is falling short.
Washington (June 8, 2012) AIDS Healthcare Foundation (AHF), the nation’s largest HIV/AIDS nonprofit medical provider welcomed the news today that the Food and Drug Administration (FDA) is delaying a ruling on and application by Gilead Sciences for the possible approval of the use of its blockbuster AIDS treatment Truvada as a form of HIV prevention pill. Gilead filed a supplemental new drug application (sNDA) for such use in December; in February 2012, the FDA granted an expedited review of Gilead’s application for approval by the FDA to market once-daily Truvada® (emtricitabine/tenofovir disoproxil fumarate) for pre-exposure prophylaxis (PrEP) to reduce the risk of HIV in uninfected adults.
AIDS group’s 70-foot, 18-wheel ‘Condom Nation’ big rig and companion Sprinter van continue national condom giveaway tour with a stop in Brooklyn, New York with partner agency Gay Men of African Descent providing free HIV testing; ‘Condom Nation’ will have a booth at the Brooklyn Pride Festival.
Yesterday, June 8th, was Caribbean American HIV/AIDS Awareness Day – an annual observance dedicated to increasing awareness of HIV/AIDS in the Caribbean American community. This is the eighth annual observance of the day, and we want to take a moment to recognize the impact that HIV/AIDS has on Caribbean American communities. Caribbean Americans come from over 30 countries, and many are affected by the epidemic here in the United States and in their home countries. In a blog post last year, Gregorio Millett, formerly of the White House Office of National HIV/AIDS Policy, touched on some of the issues and shared data on the scope of the epidemic for Caribbean Americans.
NAT is delighted to announce they are teaming up with Gaydar.co.uk for World Pride on Saturday 7 July with the message ‘Take Pride, Get Tested’. NAT and Gaydar will celebrate equality and diversity whilst encouraging the gay community to be proactive in looking after themselves and their health by getting tested regularly for HIV.
Genome-wide association studies in immune-mediated diseases have implicated a variety of inflammatory pathways, with a striking overlap of major association signals across disease subtypes. One of the most significant is the interleukin 23 (IL-23) pathway, highlighted by associations within the IL23R (interleukin 23 receptor, alpha chain) gene region to inflammatory bowel disease (IBD), psoriasis, and ankylosing spondylitis. Interleukin 23 (IL-23) is required for the optimal expansion and maintenance of Th17 lymphocytes, a key pro-inflammatory cell subset.
A couple of weeks ago, the newly creatively revitalized Matthew McConaughey hit the Cannes Film Festival with two movies to promote — Jeff Nichols’ “Mud” and Lee Daniels’ “The Paperboy.” While reviews on the former generally leaned toward the positive, the latter was something of a sensation, but for all the wrong reasons. Rounded savaged by critics — including a F grade from our man on the ground — Daniels’ film was considered trash by many, camp by some, but terrible by pretty much everyone who saw it, no matter how you slice it. And while McConaughey was briefly set to reunite with Daniels to play JFK in the director’s developing “The Butler,” another project is taking priority.
NY - The saliva of an HIV-infected man who bit a police officer doesn’t constitute a deadly weapon or dangerous instrument under state law, New York’s top court ruled Thursday.
In dismissing the aggravated assault conviction of David Plunkett, the Court of Appeals is sending the case back to a lower court for resentencing.
Timothy Brown made medical history when he became the first patient who was essentially cured of HIV, after receiving a stem cell transplant from a person who was genetically resistant to the infection. Now, doctors are hoping to build on Brown’s success by treating HIV patients using cord blood units that have the same HIV-resistant gene.